Midazolam Infusion for Seizures: Starting Dose
For refractory status epilepticus in adults, start with a loading dose of 0.2 mg/kg IV followed by a continuous infusion of 0.05-0.2 mg/kg/hr (approximately 1-4 mg/hr for a typical adult), titrating upward by 1 mg/hr increments every 15 minutes until seizures stop.
Dosing Algorithm
Loading Dose
- Administer 0.2 mg/kg IV bolus over 2-3 minutes 1
- For a 70 kg adult: approximately 14 mg
- Do NOT give rapid IV push—this increases risk of respiratory depression and hypotension
Initial Infusion Rate
The evidence supports starting at 1 mcg/kg/min (0.06 mg/kg/hr) 1:
- For a 70 kg adult: start at 4.2 mg/hr
- This translates to approximately 0.05-0.1 mg/kg/hr for most adults
Titration Strategy
Increase by 1 mcg/kg/min (0.06 mg/kg/hr) every 15 minutes until seizures stop 1:
- Maximum rate typically 5 mcg/kg/min (0.3 mg/kg/hr)
- For a 70 kg adult: maximum ~21 mg/hr
- Most patients respond at rates of 2-5 mcg/kg/min (0.12-0.3 mg/kg/hr) 2
Critical Context
When to Use Midazolam Infusion
Midazolam continuous infusion is indicated for refractory status epilepticus—seizures that persist despite:
- Adequate benzodiazepine dosing (lorazepam or diazepam)
- Second-line agent (fosphenytoin, levetiracetam, or valproate) 3
Important caveat: Lorazepam or diazepam are preferred for initial IV treatment of status epilepticus 1. Midazolam infusion is NOT first-line therapy.
Age-Specific Adjustments
The FDA label 4 and pediatric guidelines 1 specify different dosing for older adults:
Adults >60 years or debilitated patients:
- Reduce loading dose by 30-50%
- Start infusion at lower end of range (0.02-0.05 mg/kg/hr)
- Titrate more slowly due to delayed clearance
Monitoring Requirements
Essential monitoring during infusion:
- Continuous pulse oximetry
- Blood pressure every 5-15 minutes initially
- Cardiac monitoring
- Prepare for respiratory support—apnea risk is significant 1
- EEG monitoring when available to confirm seizure cessation 5
Common Pitfalls
- Inadequate loading dose: Starting infusion without a bolus delays therapeutic effect
- Too-slow titration: Waiting >15 minutes between dose increases prolongs seizure duration
- Stopping too early: Seizures may recur if infusion discontinued abruptly
- Ignoring respiratory depression: Have airway equipment and flumazenil immediately available
- Using midazolam as first-line: This violates current guidelines 3, 5—use lorazepam or diazepam first
Drug Interactions
Reduce midazolam dose by 30-50% if patient has received:
- Opioids (fentanyl, morphine) 6, 7
- Other CNS depressants
- P450-3A4 inhibitors (erythromycin, azole antifungals) 4
Adverse Effects
- Respiratory depression/apnea: Most serious risk, occurs in up to 20% 1
- Hypotension: Especially with rapid administration or in critically ill patients 8, 4
- Paradoxical agitation: Rare but documented 1
Reversal Agent
Flumazenil reverses midazolam's respiratory depression BUT:
- Also reverses anticonvulsant effects
- May precipitate seizure recurrence 1
- Use only for life-threatening respiratory depression
- Dose: 0.2 mg IV every 2-3 minutes until response 7
Duration of Therapy
- Continue infusion for 12-24 hours after seizure cessation 9
- Taper gradually (reduce by 25% every 2-4 hours) to prevent breakthrough seizures
- Mean effective infusion duration: 14.5 hours (range 12-25 hours) 9
Efficacy Data
Research demonstrates midazolam infusion controls refractory status epilepticus in 81-95% of cases 9, 10, 11, with seizure cessation typically occurring within 45 minutes at mean rates of 8 mcg/kg/min 9. Early initiation (within 15 minutes of seizure onset) significantly improves outcomes 12, 13.